Cargando…

Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets

Ginsenoside Rg3, one of the major ingredients of heat-processed ginseng, has been reported to inhibit the growth of various cancer cells. We previously reported that Rg3 inhibited the proliferation and induced apoptosis of breast cancer (MDA-MB-231) cells. In the present study, we have explored the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bo-Min, Kim, Do-Hee, Park, Jeong-Hill, Surh, Young-Joon, Na, Hye-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189477/
https://www.ncbi.nlm.nih.gov/pubmed/25337569
_version_ 1782338371597631488
author Kim, Bo-Min
Kim, Do-Hee
Park, Jeong-Hill
Surh, Young-Joon
Na, Hye-Kyung
author_facet Kim, Bo-Min
Kim, Do-Hee
Park, Jeong-Hill
Surh, Young-Joon
Na, Hye-Kyung
author_sort Kim, Bo-Min
collection PubMed
description Ginsenoside Rg3, one of the major ingredients of heat-processed ginseng, has been reported to inhibit the growth of various cancer cells. We previously reported that Rg3 inhibited the proliferation and induced apoptosis of breast cancer (MDA-MB-231) cells. In the present study, we have explored the mechanism underlying the anti-proliferative and proapoptotic effects of Rg3 in MDA-MB-231 cells, which have constitutively activated NF-κB and the mutant form of p53. Rg3 inhibited DNA binding and transcriptional activity of NF-κB and these effects were attributable to its suppression of IKKβ activity, degradation of IκBα and subsequent nuclear translocation of the p65 subunit of NF-κB. Similarly, the constitutive activation of ERK and Akt through phosphorylation was gradually reduced in MDA-MB-231 cells treated with Rg3. The pharmacological inhibitors of these kinases both U0126 (MEK1/2 inhibitor) and LY294002 (PI3K inhibitor) abrogated the NF-κB DNA binding activity in MDA-MB-231 cells. In addition, Rg3 treatment lowered the levels of the mutant p53 in concentration- and time-dependent manners. Rg3 also increased the association between p53 and its negative regulator Mdm2 in MDA-MB-231 cells. These findings suggest that Rg3 induced apoptosis in MDA-MB-231 cells, which is mediated by blocking NF-κB signaling via inactivation of ERK and Akt as well as destabilization of mutant p53.
format Online
Article
Text
id pubmed-4189477
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Society of Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-41894772014-10-21 Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets Kim, Bo-Min Kim, Do-Hee Park, Jeong-Hill Surh, Young-Joon Na, Hye-Kyung J Cancer Prev Original Article Ginsenoside Rg3, one of the major ingredients of heat-processed ginseng, has been reported to inhibit the growth of various cancer cells. We previously reported that Rg3 inhibited the proliferation and induced apoptosis of breast cancer (MDA-MB-231) cells. In the present study, we have explored the mechanism underlying the anti-proliferative and proapoptotic effects of Rg3 in MDA-MB-231 cells, which have constitutively activated NF-κB and the mutant form of p53. Rg3 inhibited DNA binding and transcriptional activity of NF-κB and these effects were attributable to its suppression of IKKβ activity, degradation of IκBα and subsequent nuclear translocation of the p65 subunit of NF-κB. Similarly, the constitutive activation of ERK and Akt through phosphorylation was gradually reduced in MDA-MB-231 cells treated with Rg3. The pharmacological inhibitors of these kinases both U0126 (MEK1/2 inhibitor) and LY294002 (PI3K inhibitor) abrogated the NF-κB DNA binding activity in MDA-MB-231 cells. In addition, Rg3 treatment lowered the levels of the mutant p53 in concentration- and time-dependent manners. Rg3 also increased the association between p53 and its negative regulator Mdm2 in MDA-MB-231 cells. These findings suggest that Rg3 induced apoptosis in MDA-MB-231 cells, which is mediated by blocking NF-κB signaling via inactivation of ERK and Akt as well as destabilization of mutant p53. Korean Society of Cancer Prevention 2014-03 /pmc/articles/PMC4189477/ /pubmed/25337569 Text en Copyright © 2014 Korean Society of Cancer Prevention This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Bo-Min
Kim, Do-Hee
Park, Jeong-Hill
Surh, Young-Joon
Na, Hye-Kyung
Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets
title Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets
title_full Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets
title_fullStr Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets
title_full_unstemmed Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets
title_short Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets
title_sort ginsenoside rg3 inhibits constitutive activation of nf-κb signaling in human breast cancer (mda-mb-231) cells: erk and akt as potential upstream targets
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189477/
https://www.ncbi.nlm.nih.gov/pubmed/25337569
work_keys_str_mv AT kimbomin ginsenosiderg3inhibitsconstitutiveactivationofnfkbsignalinginhumanbreastcancermdamb231cellserkandaktaspotentialupstreamtargets
AT kimdohee ginsenosiderg3inhibitsconstitutiveactivationofnfkbsignalinginhumanbreastcancermdamb231cellserkandaktaspotentialupstreamtargets
AT parkjeonghill ginsenosiderg3inhibitsconstitutiveactivationofnfkbsignalinginhumanbreastcancermdamb231cellserkandaktaspotentialupstreamtargets
AT surhyoungjoon ginsenosiderg3inhibitsconstitutiveactivationofnfkbsignalinginhumanbreastcancermdamb231cellserkandaktaspotentialupstreamtargets
AT nahyekyung ginsenosiderg3inhibitsconstitutiveactivationofnfkbsignalinginhumanbreastcancermdamb231cellserkandaktaspotentialupstreamtargets